Società Consun Pharmaceutical Group Limited Deutsche Boerse AG
Azioni
C1P
KYG2524A1031
Prodotti farmaceutici
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,66 EUR | +21,10% | -17,50% | +24,53% |
Attività
Numero di dipendenti: 3 127
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Kidney Medicines
67,2
%
| 1 825 | 67,1 % | 1 924 | 67,2 % | +5,43% |
Gynaecology and Paediatrics Drugs
11,3
%
| 278 | 10,2 % | 325 | 11,3 % | +16,58% |
Contrast Medium
6,0
%
| 190 | 7,0 % | 172 | 6,0 % | -9,34% |
Orthopedics Medicines
5,9
%
| 204 | 7,5 % | 169 | 5,9 % | -16,83% |
Dermatologic Medicines
5,0
%
| 134 | 4,9 % | 142 | 5,0 % | +6,00% |
Hepatobiliary Medicines
3,1
%
| 54 | 2,0 % | 88 | 3,1 % | +62,55% |
Others
1,5
%
| 36 | 1,3 % | 43 | 1,5 % | +17,60% |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 721 | 100,0 % | 2 862 | 100,0 % | +5,20% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Meng An
CEO | Chief Executive Officer | 52 | 24/03/21 |
Pei Cheng Fang
DFI | Director of Finance/CFO | 45 | 01/08/10 |
Han Xing Xu
BRD | Director/Board Member | 30 | 01/11/20 |
Yu Jun Chen
BRD | Director/Board Member | 44 | 01/05/13 |
Hai En Gao
SEC | Corporate Secretary | 56 | - |
Chi Ming Yau
SEC | Corporate Secretary | 56 | 01/03/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Quan Zhu
BRD | Director/Board Member | 84 | 24/12/12 |
Zhong Shi Feng
BRD | Director/Board Member | 65 | 02/12/13 |
Yu Jun Chen
BRD | Director/Board Member | 44 | 01/05/13 |
Meng An
CEO | Chief Executive Officer | 52 | 24/03/21 |
Han Xing Xu
BRD | Director/Board Member | 30 | 01/11/20 |
Li Hua Zhang
BRD | Director/Board Member | 47 | 09/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 817 901 427 | 349 439 073 ( 42,72 %) | 0 | 42,72 % |
Coordinate società
Consun Pharmaceutical Group Ltd.
71 Dong Peng Avenue, Eastern Section Guangzhou Economic & Technological
510760, Guangzhou
+86 20 8226 4529
http://www.chinaconsun.comSettore
Vendite per attività
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,26% | 22,46 Mrd | |
+18,55% | 15,04 Mrd | |
+18,94% | 13,98 Mrd | |
+56,80% | 13,15 Mrd | |
-9,52% | 6,89 Mrd | |
-0,05% | 6,79 Mrd | |
-8,87% | 5,73 Mrd | |
+13,66% | 5,71 Mrd | |
+4,00% | 4,69 Mrd |
- Borsa valori
- Azioni
- Azione 1681
- Azione C1P
- Società Consun Pharmaceutical Group Limited